AngioDynamics has partnered with the Society of Urologic Oncology Clinical Trials Consortium on the PRESERVE Study, exploring use of the NanoKnife System for ablation of prostate tissue in an intermediate-risk population. To learn more, visit angiopreserve.com.
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, vascular interventions and therapies, and oncology. Diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories drainage products, thrombolytic products and venous products. For more information visit www.angiodynamics.com.